GH Research
GHRS
35 hedge funds and large institutions have $309M invested in GH Research in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
6% more funds holding
Funds holding: 33 → 35 (+2)
0.87% more ownership
Funds ownership: 61.72% → 62.59% (+0.87%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less capital invested
Capital invested by funds: $587M → $309M (-$278M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
+$14.7M |
| 2 |
O
OrbiMed
New York
|
+$2.51M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$923K |
| 4 |
Morgan Stanley
New York
|
+$743K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$361K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
-$5.65M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.45M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.74M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.29M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$535K |
GHRS Hedge Fund Activity: Q2 2022 in Review
35 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in GH Research (GHRS) for Q2 2022, worth a combined $309M — down 47% from $587M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GHRS positions and 2 closed out — a net gain of 3 holders — while 12 added to existing stakes and 8 trimmed.
The largest buyer was VR Adviser, adding an estimated $14.7M. The largest seller was Verition Fund Management, cutting an estimated $5.65M.
- 35 institutional investors held GH Research (GHRS) as of Q2 2022, up from 33 in Q1 2022.
- Funds reported $309M of GH Research stock for Q2 2022, down 47% quarter-over-quarter.
- 5 funds opened new GH Research positions in Q2 2022 and 2 closed out, a net change of +3 holders.
- The largest GH Research buyer in Q2 2022 was VR Adviser, an estimated $14.7M added.
- The largest GH Research seller in Q2 2022 was Verition Fund Management, an estimated $5.65M sold.
Based on aggregated 13F filings for Q2 2022.